Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Non-cash Items: 2019-2024

Historic Non-cash Items for IDEAYA Biosciences (IDYA) over the last 6 years, with Dec 2024 value amounting to $90.2 million.

  • IDEAYA Biosciences' Non-cash Items rose 11.87% to $108.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $108.4 million, marking a year-over-year increase of 11.87%. This contributed to the annual value of $90.2 million for FY2024, which is 119.46% up from last year.
  • According to the latest figures from FY2024, IDEAYA Biosciences' Non-cash Items is $90.2 million, which was up 119.46% from $41.1 million recorded in FY2023.
  • In the past 5 years, IDEAYA Biosciences' Non-cash Items registered a high of $90.2 million during FY2024, and its lowest value of $15,700 during FY2020.
  • Moreover, its 3-year median value for Non-cash Items was $41.1 million (2023), whereas its average is $53.1 million.
  • In the last 5 years, IDEAYA Biosciences' Non-cash Items tumbled by 99.73% in 2020 and then skyrocketed by 67,532.85% in 2022.
  • Over the past 5 years, IDEAYA Biosciences' Non-cash Items (Yearly) stood at $15,700 in 2020, then spiked by 163.69% to $41,400 in 2021, then soared by 67,532.85% to $28.0 million in 2022, then soared by 46.79% to $41.1 million in 2023, then surged by 119.46% to $90.2 million in 2024.